Anesthesiology Doctors in Minnetonka, MN Accepting Medicare

8 Anesthesiology doctors found. Showing 1 - 8

Alexander K Yue, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 13911 Ridgedale Dr, Suite 350, Minnetonka, MN 55305 Phone: 952-932-9012

Thomas K Yue, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 13911 Ridgedale Dr, Suite 350, Minnetonka, MN 55305 Phone: 952-932-0998

James Stephen Moy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 13911 Ridgedale Dr, Suite 350, Minnetonka, MN 55305 Phone: 952-932-9012

Subba Raju, MBBS Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 13911 Ridgedale Drive, Suite 350, Minnetonka, MN 55305 Phone: 952-932-9012    Fax: 952-932-7122

Judith Mw Meisner, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4647 Woodridge Rd, Minnetonka, MN 55345 Phone: 952-931-3961

Roger Douglas Lillemoen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 13911 Ridgedale Dr, Suite 350, Minnetonka, MN 55305 Phone: 952-932-9012

Halima Ali Qureshi, MBBS Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 13911 Ridgedale Dr, Suite 350, Minnetonka, MN 55305 Phone: 952-932-9012

Douglas Kent Vansteenwyk, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 13911 Ridgedale Drive, Suite 350, Minnetonka, MN 55305 Phone: 952-932-9012    Fax: 952-932-7122

News Archive

CAM314 randomized Phase 3 clinical trial results released

Genzyme Corporation announced data from its CAM314 randomized Phase 3 clinical trial comparing Campath (alemtuzumab) in combination with Fludara (fludarabine phosphate) (FluCAM) to Fludara alone in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) demonstrated that the FluCAM regimen significantly reduced the risk of disease progression or death compared to single-agent Fludara.

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

Now, a new preprint research paper describes a chimpanzee adenovirus-vectored vaccine that, when administered intranasally in rhesus macaques, led to a robust immune response and demonstrated protection against infection by the virus that causes COVID-19, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The preprint is published on the bioRxiv server.

Age has no impact on survival after bone marrow transplant

Age alone should not determine whether an older patient with acute myeloid leukemia or myelodysplastic syndrome receives a blood stem cell transplant from a matched donor, researchers of the Center for International Blood and Marrow Transplant Research reported today at the 50th annual meeting of the American Society of Hematology.

Viewpoints: CLASS decision ends fear of government bailout; the strengths and failings of U.S. health care

The problem, as numerous experts warned at the time, was whether the program could be run, as the law required, in a way that made it financially solvent for at least 75 years. The difficulty with the CLASS Act was ensuring that premiums could be set low enough to attract widespread participation but high enough to pay tbenefits. The risk was that the program would attract the sickest participants, who thought they might need its protections, and thereby drive premium prices ever higher in a spiral of dysfunctionhe promised.

Read more Medical News

› Verified 2 days ago